VistaGen Therapeutics, Inc. — Form D
VistaGen Therapeutics, Inc. of South San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-09-21. The offering totals $5.8M, of which $4.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-09-21
- Form: D
- Accession: 0001415889-18-001409
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.8M
- Amount sold: $4.8M
- Remaining: $971K
- Investors: 33
- Date of first sale: 2018-06-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-321921
Issuer
- Name: VistaGen Therapeutics, Inc.
- CIK: 0001411685
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: 343 Allerton Avenue, South San Francisco, CA, 94080
- Phone: 650-577-3600
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Mark A Smith | Executive Officer | Old Bethpage, NY |
| Jon S Saxe | Director | Austin, TX |
| Jerrold D Dotson | Executive Officer | South San Francisco, CA |
| Joanne M Curley | Director | South San Francisco, CA |
| Shawn K Singh | Director | South San Francisco, CA |
| Shawn K Singh | Executive Officer | South San Francisco, CA |
| Jerry B Gin | Director | South San Francisco, CA |
| Ann M Cunningham | Director | South San Francisco, CA |
| Reid G Adler | Executive Officer | South San Francisco, CA |
| Margaret M FitzPatrick | Director | South San Francisco, CA |
| Mary L Rotunno | Director | South San Francisco, CA |
| Gregory A Bonfiglio | Director | San Francisco, CA |
| Mark A McPartland | Executive Officer | South San Francisco, CA |
| Ann K Cunningham | Director | South San Francisco, CA |
| H. Ralph Snodgrass | Director | South San Francisco, CA |
| H. Ralph Snodgrass | Executive Officer | South San Francisco, CA |
| Underdown J Brian | Director | South San Francisco, CA |
| A. Franklin Rice | Executive Officer | South San Francisco, CA |
| Brian J Underdown | Director | Toronto, A6 |
Other filings by this issuer (7)
More